相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。p-SCN-Bn-HOPO: A Superior Bifunctional Chelator for 89Zr ImmunoPET
Melissa A. Deri et al.
BIOCONJUGATE CHEMISTRY (2015)
Di-macrocyclic terephthalamide ligands as chelators for the PET radionuclide zirconium-89
Darpan N. Pandya et al.
CHEMICAL COMMUNICATIONS (2015)
Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with Zr-89(4+): comparison with desferrioxamine-B
Michelle T. Ma et al.
DALTON TRANSACTIONS (2015)
Novel Bifunctional Cyclic Chelator for 89Zr Labeling-Radiolabeling and Targeting Properties of RGD Conjugates
Chuangyan Zhai et al.
MOLECULAR PHARMACEUTICS (2015)
An octadentate bifunctional chelating agent for the development of stable zirconium-89 based molecular imaging probes
Malay Patra et al.
CHEMICAL COMMUNICATIONS (2014)
Matching chelators to radiometals for radiopharmaceuticals
Eric W. Price et al.
CHEMICAL SOCIETY REVIEWS (2014)
Rational Design, Synthesis, and Evaluation of Tetrahydroxamic Acid Chelators for Stable Complexation of Zirconium( IV)
Francois Guerard et al.
CHEMISTRY-A EUROPEAN JOURNAL (2014)
Charting the mechanism and reactivity of zirconium oxalate with hydroxamate ligands using density functional theory: implications in new chelate design
Jason P. Holland et al.
DALTON TRANSACTIONS (2014)
Alternative Chelator for 89Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)
Melissa A. Deri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Quantitative ImmunoPET of Prostate Cancer Xenografts with 89Zr- and 124I-Labeled Anti-PSCA A11 Minibody
Scott M. Knowles et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Production of 89Zr via the 89Y(p,n) 89Zr reaction in aqueous solution: Effect of solution composition on in-target chemistry
Mukesh K. Pandey et al.
NUCLEAR MEDICINE AND BIOLOGY (2014)
Investigation of Zr(IV) and Zr-89(IV) complexation with hydroxamates: progress towards designing a better chelator than desferrioxamine B for immuno-PET imaging
Francois Guerard et al.
CHEMICAL COMMUNICATIONS (2013)
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with 18F-FDG and 89Zr-Trastuzumab PET
Yelena Y. Janjigian et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Zirconium-89 labeled panitumumab: a potential immuno-PET probe for HER1-expressing carcinomas
Sibaprasad Bhattacharyya et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
PET imaging with 89Zr: From radiochemistry to the clinic
Melissa A. Deri et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Imaging the L-Type Amino Acid Transporter-1 (LAT1) with Zr-89 ImmunoPET
Oluwatayo F. Ikotun et al.
PLOS ONE (2013)
PET of Signal Transduction Pathways in Cancer
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Treatment of HER2-positive breast cancer: current status and future perspectives
Carlos L. Arteaga et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
89Zr-Radiolabeled Trastuzumab Imaging in Orthotopic and Metastatic Breast Tumors
Albert J. Chang et al.
PHARMACEUTICALS (2012)
A practical guide to the construction of radiometallated bioconjugates for positron emission tomography
Brian M. Zeglis et al.
DALTON TRANSACTIONS (2011)
In vivo biodistribution and accumulation of 89Zr in mice
Diane S. Abou et al.
NUCLEAR MEDICINE AND BIOLOGY (2011)
PET Tracers Based on Zirconium-89
Yin Zhang et al.
CURRENT RADIOPHARMACEUTICALS (2011)
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
Thaddeus J. Wadas et al.
CHEMICAL REVIEWS (2010)
Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer
E. C. Dijkers et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
Lars R. Perk et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Jason P. Holland et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine
Maria J. W. D. Vosjan et al.
NATURE PROTOCOLS (2010)
Antibodies and Antimatter: The Resurgence of Immuno-PET
Anna M. Wu
JOURNAL OF NUCLEAR MEDICINE (2009)
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Eli C. F. Dijkers et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Standardized methods for the production of high specific-activity zirconium-89
Jason P. Holland et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Immuno-PET: A navigator in monoclonal antibody development and applications
Guus A. M. S. van Dongen et al.
ONCOLOGIST (2007)